---
title: "Pharmaceutical companies' role in state vaccination policymaking: the case of human papillomavirus vaccination"
analyst: amantonio
article:
  type: article
  authors: Mello
  year: 2012
  magazine: Am J Public Health
  link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483914/
  pubmed: PMC3483914
---

Here the aggressive lobbying by Merck is being analyzed, and how it led to the HPV vaccine becoming mandatory is several states just a year after being licensed.
Only 48% of completed HPV vaccine clinical trial results [were published](https://www.ncbi.nlm.nih.gov/pubmed/29347995).
